Immunological and virological effects of ribavirin in hepatitis C after liver transplantation

Quadri Defilippis, Rafael; Giostra, Emiliano; Roskams, Tania; Pawlotsky, Jean-Michel; Mentha, Gilles; Rubbia-Brandt, Laura; Perrin, Luc; Hadengue, Antoine; Negro, Francesco

Professional article

English

Immunological and virological effects of ribavirin in hepatitis C after liver transplantation

ContributorsQuadri Defilippis, Rafael; Giostra, Emiliano; Roskams, Tania; Pawlotsky, Jean-Michel; Mentha, Gilles; Rubbia-Brandt, Laura; Perrin, Luc; Hadengue, Antoine; Negro, Francesco

Published inTransplantation, vol. 73, no. 3, p. 373-378

Publication date2002

Abstract

Hepatitis C recurring after liver transplant may cause progressive liver dysfunction, and available treatment regimens are unsatisfactory. A better understanding of the mechanisms of action of drugs currently used to manage hepatitis C would be helpful.

Keywords

Adult
Antiviral Agents/therapeutic use
Cytokines/genetics
Female
Hepatitis C/drug therapy/virology
Humans
Liver/virology
Liver Transplantation/adverse effects
Male
Middle Aged
RNA, Messenger/analysis
RNA, Viral/analysis
Ribavirin/therapeutic use

Affiliation

Research group

Citation (ISO format)

QUADRI DEFILIPPIS, Rafael et al. Immunological and virological effects of ribavirin in hepatitis C after liver transplantation. In: Transplantation, 2002, vol. 73, n° 3, p. 373–378.

Article (Published version)

Identifiers

PID : unige:16907
PMID : 11884933

Commercial URLhttp://vir.sgmjournals.org/content/81/6/1485.full

ISSN of the journal0041-1337

543views

0downloads

Creation07/14/2011 10:52:00 AM

First validation07/14/2011 10:52:00 AM

Update time03/14/2023 4:54:03 PM

Status update03/14/2023 4:54:03 PM

Last indexation01/15/2024 10:32:54 PM

Archive ouverte UNIGE

Immunological and virological effects of ribavirin in hepatitis C after liver transplantation

Hepatitis C recurring after liver transplant may cause progressive liver dysfunction, and available treatment regimens are unsatisfactory. A better understanding of the mechanisms of action of drugs currently used to manage hepatitis C would be helpful.

Technical informations